The antinociceptive effect of two 5-HT4 agonists, BIMU 1 and BIMU 8, were examined in mice and rats by using the hot-plate, abdominal constriction and paw- 
to stimulate guinea-pig ileum motility through activation of intramural cholinergic nerve pathways subserving peristalsis (2, 3) since this effect is abolished by antimuscarinic treatment (3) . BIMU 1 and BIMU 8 are two benzimidazolone derivatives which exhibit 5HT4 ago&tic properties (4, 5) .
These two compounds are endowed not only with the ability to potentiate electrically stimulated twitch responses in guinea-pig ileum longitudinal (6) and circular muscle (3) , but also to stimulate the contractility of the gastric pouch in conscious dogs (7, 8) and detrusor muscle in human (9) .
Moreover, BIMU 1 and BIMU 8 facilitate in vivo ACh release in the frontal cortex of rats as shown by microdialysis studies (IO). This facilitatory effect was blocked by the selective 5HT4
antagonists GR 125487 and GR 113808 indicating, therefore, that this potentiation of ACh release is mediated by 5HT4 receptors. It has long been known that ACh (11) . selective Ml agonists such as McN-A-343 and AF-102B (12) , unselective muscarinic agonists such as tremorine (13) , oxotremorine (14, 15) , arecoline (16) , pilocarpine (17) and cholinesterase inhibitors such as physostigmine (18, 19) and diisopropyl phosphorofluoridate (20) induce antinociception in laboratory animals by the activation of the cholinergic system. Moreover, the amplification of cholinergic neurotransmission induced by antagonism of muscarinic autoreceptors (2 1, 22, 23) or, alternatively, by interaction with heteroreceptors (24) located on presynaptic cholinergic terminals, produces a central antinociceptive effect. In the present work, the ability of BIMU 1 and BIMU 8 for modifying pain hreshold was investigated.
Methods

Animals
Male Swiss albino mice (23-30 g ) and Wistar rats (200-300 g) from the Morini breeding farm were used. Fifteen mice and four rats were housed per cage. The cages were placed into the experimental room 24 h before the test for acclimatization. The animals were kept at 23fl 'C with a 12 h light/dark cicle, light at 7 a.m., with food and water ad libitum. Animals were randomly assigned to a control (saline solution) or a treated group (BIMU 1 -BIMU 8). Both groups received a pretreatment consisting in the injection of one of the following antagonists: atropine, naloxone, SD2 205-557, GR 125487, hemicholinium-3 (HC-3), CGP-35348 or reserpine. All the antagonists were injected 15 min before treatment with the exception of HC-3, CGP 35348 and reserpine. HC-3 and CGP-35348 were administered respectively 5 h and 5 min before treatment whereas reserpine was injected twice, 48 and 24 h, before the test. All animals used were drug naive. All experiments were carried out according to the guidelines of the European Community
Council.
Hot nlate test
The method adopted was described by O'Callaghan and Holtzman (25) . Mice were placed inside a stainless steel container, thermostatically set at 52.5 + 0.1 "C in a precision water-bath from KW Mechanical Workshop, Siena, Italy. Reaction times (s), were measured with a stop-watch about 30 min before pretreatment (pretest) and 15, 30 and 45 min after treatment. The endpoint used was the licking of the fore or hind paws. Those mice scoring below 12 and over 18 s in the pretest were rejected (30%). An arbitrary cut-off time of 45 s was adopted at which the animals were removed from the hot-plate and given a score of 45 s.
Abdominal constriction test
The test was performed in mice according to Koster et al. (26) . Mice were injected i.p. with a 0.6% solution of acetic acid (10 ml kg-l). The number of stretching movements was counted for 10 min, starting 5 min after acetic acid injection. Both BIMU 1 and BIMU 8 were administered 10 n-tin before acetic acid injection.
Paw uressure
The nociceptive threshold in the rat was determined with an analgesimeter (Ugo Basile, Varese, Italy), according to the method described by Leighton et al. (27) . Threshold pressure was measured about 30 min before treatment (pretest) and 15, 30 and 45 min after treatment. Rats scoring below 50 g or over 85 g during the pretest were rejected (25%). An arbitrary cut-off value of 250 g was adopted.
Rota-rod test
The apparatus consisted of a base platform and a rotating rod of 3 cm diameter with a non-slippery The performance time was measured before and 15,30 and 45 min after treatment.
Nucleus basalis magnocellularis lesions
Under ketamine anaesthesia (100 mg kg-' i.p.) bilateral lesions of the rat nucleus basalis magnocellularis (NBM) were made by stereotaxic injection of 0.5 ~1 of 0.12 M quisqualic acid dissolved in 50 mM sodium phosphate buffer (pH=7.4) with a 10 l.tl Hamilton syringe. The injection lasted 3 min and the syringe was left in position for 5 min after the completion of the infusion. The following coordinates, taken from Paxinos and Watson (29) stereotaxic atlas, were used: 0.5 mm posterior to bregma, 2.8 mm lateral, 6.8 mm below dura. Twenty days after surgery the weight of the rats was only slightly below that of controls and they looked healthy. In the sham-operated rats the syringe needle was lowered into the cortex and no quisqualic acid was injected. At the end of the experiments the location and size of the lesions were checked by histological examination on 10 l.trn-thick slices stained with the cresyl violet according to the Nissl method.
. .
Choline acetvltransferase determtnauo n
After completing the behavioural paw-pressure test, lesioned and sham operated rats were decapitated. Brains were then removed and cortexes dissected out. Choline acetyltransferase activity was determined according to the method of Fonnum (30) . The following drugs were used: 
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* P< 0.01. A P < 0.05 in comparison with sali-PC 0 01 versus saline-BIMU 1 or saline-B&III 8 treated mice. The number of mice ranged from 8-26 with the exception of saline-saline were n = 28-30. 
147.4&X8*
The number of rats ranged from 6-9 with the exception of (x) where n = 13. (Fig. 3) . As shown in Table 2 , BIMU 1 and BIMU 8 antinociception was confirmed in TABLE 3 Effect of BIMU 1 and BIMU 8 in the mouse rota-rod test. the rat paw-pressure test where the time-course reflected that observed with the hot-plate test (Fig. 1) . In the paw-pressure test, no antinociception by BIMU 1 and BIMU 8 was detected in rats with bilateral lesions of the NBM (Table 2 ). In these rats cortical choline acetyltranferase activity was reduced by 55 f 6.1% (n=5) as compared with the sham operated rats. The antinociceptive effect of morphine (5 mg kg-' i.p.) in the lesioned rats did not differ from that in the sham operated rats ( (34) and animals (12, 13, 14, 15, 16, 17, 18, 19, 20) . A large difference exists between the analgesia induced in animals by both BIMU 1 and BIMU 8 and that induced by direct muscarinic agonists and cholinesterase inhibitors. In fact, while 5HT4 agonists produce antinociception without any visible side effect, the direct muscarinic agonists and the cholinesterase inhibitors provoke, at the same time, a clear cholinergic symptomatology (tremors, sialorrhoea, diarrhoea, lacrimation etc.). Other neurotransmitter systems did not appear to be involved in BIMU 1 and BIMU 8 antinociception since the opioid antagonist naloxone, the GABA, antagonist CGP 35348 and reserpine, were all unable to prevent 5-HT4 agonist-induced analgesic effect. The doses and administration schedules of the above-mentioned drugs were suitable for preventing antinociception induced respectively by morphine (23), GABA, agonist baclofen (35) and the antidepressant drugs clomipramine and amitriptyline (36) . The prevention of BIMU 1 and BIMU 8 antinociception produced by the 5-HT4 antagonists SDZ 205-557 (37) and GR 125487 (38) suggests, moreover, that the central serotoninergic system exerts an excitatory tone on the cholinergic system. BIMU 1 and BIMU 8, by activating serotoninergic heteroreceptors, increase ACh release as well documented by microdialysis experiments (10).
Treatment
The results obtained have shown a good relationship between the antinociceptive effect of BIMU 1 and BIMU 8 and the potentiation of cerebral ACh release described by Consolo et al. (10) . In fact, the latency required to reach the maximum amplification of ACh release (20 min) by BIMU 1 and BIMU 8 was equal to that required for reaching their antinociceptive peak (15 min). The fact that physostigmine was used in rats employed for ACh collection from the cerebral cortex but not in those used for antinociceptive tests, could explain the more lasting effects of BIMU 1 and BIMU 8 on ACh release as compared to antinociception. In summary our results have shown that BIMU 1 and BIMU 8 are able to induce antinociception by potentiating endogenous cholinergic activity.
